Volume 6 Supplement 3

AIDS Vaccine 2009

Meeting abstracts

Edited by Anna Laura Ross

AIDS Vaccine 2009. Go to conference site.

Paris, France19-22 October 2009

Concatenated PDF 6S3

Page 5 of 10

P11-04. PEGylated poly [2-(N,N-dimethylamino) ethyl methacrylate] as mucosal DNA delivery vector improves HIV-1-specific immune responses

Authors: Y Qiao, Y Huang, XY Yue, C Qiu, LD Deng, YM Wan, JF Xing, CY Zhang, SH Yuan, AJ Dong and JQ Xu

Citation: Retrovirology 2009 6(Suppl 3):P149

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P11-05. Induction of CD8+ T cell mediated immune responses through skin and mucosa: identification of immunostimulatory versus tolerogenic dendritic cells

Authors: B Dubois, M Gomez de Agüero, M Le Borgne, M Gouanvic, M Vocanson and D Kaiserlian

Citation: Retrovirology 2009 6(Suppl 3):P150

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P11-06. Intravaginal administration of HIV-1ZM96 gp140 augments systemic and mucosal antibody responses following systemic priming with adjuvanted protein

Authors: M Cranage, C Fraser, A Cope, P McKay, W Elsley, M Page, AN Mahmoud, K DaCosta, P Fletcher, N Armanasco, N Almond and R Shattock

Citation: Retrovirology 2009 6(Suppl 3):P151

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P11-07. Characterization of a new TZM-bl cell line that expresses human FcαR(CD89)

Authors: LG Perez, MR Costa and DC Montefiori

Citation: Retrovirology 2009 6(Suppl 3):P152

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P11-08. Abstract withdrawn

Authors:

Citation: Retrovirology 2009 6(Suppl 3):P153

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P11-09. Mucosal vaccination with a transferrin-gp140 conjugate via the nasal but not vaginal route elicits robust systemic and vaginal IgG and IgA responses

Authors: JF Mann, DS Miranda de Stegmann, K Klein, D Stieh, MP Cranage, RJ Shattock and PF McKay

Citation: Retrovirology 2009 6(Suppl 3):P154

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P11-10. Modulation of intestinal T cells following infection of macaques with live attenuated and conditionally replication-competent SIV

Authors: MS Manoussaka, R Stebbings, R Quartey-Papafio, M Robinson, M Page, AT Das, W Kleibeuker, B Klaver, B Berkhout, N Almond and M Cranage

Citation: Retrovirology 2009 6(Suppl 3):P155

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P11-11. Stable lyophilised gel vehicles for vaginal administration of recombinant C-clade HIV-1 trimeric CN54gp140

Authors: L Donnelly, RM Curran, RJ Morrow, VL Kett, GP Andrews, RK Malcolm, AD Woolfson and RJ Shattock

Citation: Retrovirology 2009 6(Suppl 3):P156

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P11-12. A novel vaginal ring device for the sustained delivery of recombinant C-clade HIV-1 CN54gp140

Authors: RJ Morrow, L Donnelly, RM Curran, RK Malcolm, AD Woolfson, GP Andrews and R Shattock

Citation: Retrovirology 2009 6(Suppl 3):P157

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P11-13. Antigen presentation and immune priming of CCR5-ECL1 receptor in Peyer's patches B cells

Authors: L Lopalco, L Diomede, C Pastori, E Soprana and A Siccardi

Citation: Retrovirology 2009 6(Suppl 3):P158

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P11-14. Analysis of mucosal antibodies in genital fluids of HIV seropositive subjects from Cambodian and Italian cohorts

Authors: L Lopalco, L Scotti, C Pastori, M Ngyen, J Nouhin, D Ferrari and G Pancino

Citation: Retrovirology 2009 6(Suppl 3):P159

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P11-15. Induction of a mucosal immune response to HIV after systemic immunization with poly(lactic acid) nanoparticles formulated with gag antigen and polyI:C

Authors: C Primard, C Weber, F Martinon, S Munier, A Calamel, E Luciani, T Delair, R Le Grand and B Verrier

Citation: Retrovirology 2009 6(Suppl 3):P160

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P11-16. Transfer of HIV-1 from Langerhans and interstitial dendritic cells to T lymphocytes: protection mediated by antibodies?

Authors: M Peressin, V Holl, S Schmidt, T Decoville, J Penichon and C Moog

Citation: Retrovirology 2009 6(Suppl 3):P161

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P11-17. Intermittent rectal shedding of multiple human adenovirus serotypes among HIV-positive MSM

Authors: M Curlin, C Celum, J Sanchez, S Selke, J Baeten, M Huang, R Zuckerman, X Lu, D Erdman and L Corey

Citation: Retrovirology 2009 6(Suppl 3):P162

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P11-18. Immunogenicity of Lactobacillus gasseri-FliC as an oral mucosal vaccine adjuvant for HIV

Authors: S Gunderson, S Nordone, A LaVoy, L Zhang, T Klaenhammer and G Dean

Citation: Retrovirology 2009 6(Suppl 3):P163

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P11-19. Altered mucosal distribution of SIV-specific T cells in Rhesus macaques infected with the live-attenuated Rev-independent SIV

Authors: A Valentin, A von Gegerfelt, C Alicea, V Patel, ML Marthas, K Van Rompay, GN Pavlakis and BK Felber

Citation: Retrovirology 2009 6(Suppl 3):P164

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P11-20. HIV-1 gp41-specific mucosal IgAs from highly exposed but IgG seronegative women block HIV-1 epithelial transcytosis and neutralize CD4+ cell infection

Authors: D Tudor, M Derrien, L Diomede, M Houimel, A Drillet, C Moog, J Reynes, L Lopalco and M Bomsel

Citation: Retrovirology 2009 6(Suppl 3):P165

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P11-21. Induction of persistent mucosal humoral and cellular responses following immunization of mice with HIV-1 envelope protein in inulin-derived adjuvants

Authors: AD Cristillo, G Ferrari, L Hudacik, D Thompson, B Bowen, B Lewis, L Galmin, J Suschak, N Petrovsky, P Markham and R Pal

Citation: Retrovirology 2009 6(Suppl 3):P166

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P12-01. Construction and characterization of recombinant envelope glycoproteins derived from HIV-1 pre-seroconversion strains as potential vaccine immunogens

Authors: S Mohana Rama Reddy, RJ Center, K Suzuki, P Gorry, A Kelleher and DF Purcell

Citation: Retrovirology 2009 6(Suppl 3):P167

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P12-02. Cell-surface display and panning of HIV-1 derived envelope proteins

Authors: T Bruun, A Kliche and R Wagner

Citation: Retrovirology 2009 6(Suppl 3):P168

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P12-03. Generation of novel recombinant HIV-1 glycoproteins for expression on virus like particles

Authors: M Tagliamonte, M Visciano, M Tornesello, FM Buonaguro and L Buonaguro

Citation: Retrovirology 2009 6(Suppl 3):P169

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P12-04. Topology of the C-terminal tail of HIV-1 gp41: Differential exposure of the Kennedy epitope on cell and viral membranes

Authors: JD Steckbeck, TJ Sturgeon, C Sun and RC Montelaro

Citation: Retrovirology 2009 6(Suppl 3):P170

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P12-05. Using combinatorial phage-display libraries as a source of mimetic peptides of three HIV-1 envelope epitopes

Authors: Y Palacios-Rodriguez, T Gazarian and K Gazarian

Citation: Retrovirology 2009 6(Suppl 3):P171

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P12-06. A 'non-self' mimic of the natural epitope of anti-HIV antibody 2G12 shows enhanced antigenicity

Authors: KJ Doores, Z Fulton, CN Scanlan, MR Wormald, RA Dwek, IA Wilson, DR Burton and BG Davis

Citation: Retrovirology 2009 6(Suppl 3):P172

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P12-07. Novel HIV vaccines using chimeric influenza HA vectors

Authors: DA Steinhauer, WA Langley, G Talekar and Z Li

Citation: Retrovirology 2009 6(Suppl 3):P173

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P12-08. Membrane-specific antibodies that simultaneously bind to gp41 of HIV-1 and membrane lipid epitopes are induced by immunization with liposomes

Authors: Z Beck, N Karasavvas, GR Matyas and CR Alving

Citation: Retrovirology 2009 6(Suppl 3):P174

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P12-09. Immune responses in controlled and uncontrolled HIV infection to a designed HIV immunogen sequence focused on conserved regions of the viral genome

Authors: B Mothe, A Llano, J Ibarrondo, C Miranda, M Rolland, N Frahm, A Khatri, D Heckerman, J Mullins and C Brander

Citation: Retrovirology 2009 6(Suppl 3):P175

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P12-10. Immunogen utilizing the stable interaction of cytoplasmic tails of HIV-1 envelope and cores

Authors: H Takahashi, M Tobiume and T Sata

Citation: Retrovirology 2009 6(Suppl 3):P176

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P12-11. Resistance to the CD4 mimetic mini protein M48-U1 induces changes in a highly conserved region on the HIV-1 gp120 envelope protein

Authors: K Grupping, L Heyndrickx, J Michiels, G Martin, L Martin and G Vanham

Citation: Retrovirology 2009 6(Suppl 3):P177

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P12-12. Analysis of antibody and B cell responses following inoculation with computationally designed HIV-1 2F5 epitope scaffold proteins

Authors: P Dosenovic, J Guenaga, G Ofek, D Baker, W Schief, PD Kwong, GB Karlsson Hedestam and RT Wyatt

Citation: Retrovirology 2009 6(Suppl 3):P178

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P12-13. Structure-guided design and immunological characterization of immunogen constructs presenting the HIV-1 gp120 V3 loop on a CTB scaffold

Authors: M Totrov, X Jiang, X Kong, S Cohen, C Krachmarov, C Williams, T Cardozo, M Gorny, S Wang, S Lu, A Pinter and S Zolla-Pazner

Citation: Retrovirology 2009 6(Suppl 3):P179

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P12-14. Design of hydrophilic, helical peptides that mimic the 4E10 epitope of HIV-1 gp41

Authors: IC Lorenz, CL Martin, S Hoffenberg, SK Phogat and SM Kaminsky

Citation: Retrovirology 2009 6(Suppl 3):P180

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P12-15. Replication enhancement of an alphaviral-lentiviral replicating chimeric particle (RCP) vaccine

Authors: K Young, C Beard and R Johnston

Citation: Retrovirology 2009 6(Suppl 3):P181

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P12-16. Biochemical and immunological characterization of the plant-derived candidate HIV-1 mucosal vaccine CTB-MPR

Authors: N Matoba, I Cherni, S Kessans, J Frater, K Preston, M Bomsel and TS Mor

Citation: Retrovirology 2009 6(Suppl 3):P182

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P13-01. Crystal structure and function of a monoclonal antibody against primate CD4 that blocks HIV/SIV infection

Authors: A Pegu, JC Boyington, W Kong, W Shi, PD Kwong and GJ Nabel

Citation: Retrovirology 2009 6(Suppl 3):P183

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P13-02. Cytoskeletal proteins bound to HSP70 may elicit resistance to SIV infection of CD4+ T cells

Authors: L Bergmeier, K Babaahmady, J Pido-Lopez, K Heesom, CG Kelly, T Whittall and T Lehner

Citation: Retrovirology 2009 6(Suppl 3):P184

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P13-03. Neutralizing antibody to HIV-1 Env from hyperimmune bovine colostrum as a mucosal microbicide strategy for preventing virus transmission

Authors: M Kramski, R Center, G Rawlin, C Siebentritt and DF Purcell

Citation: Retrovirology 2009 6(Suppl 3):P185

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P13-04. HIV positive women empowerment is equal to hiv prevalence reduction

Authors: MM Akolo, J Kimani, S Barassa, S Lipesa and I Gelmon

Citation: Retrovirology 2009 6(Suppl 3):P186

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P13-05. Factors associated with pregnancy during the HVTN 503/Phambili trial, a phase IIB HIV trial of the Merck Ad-5 multi-clade HIV vaccine

Authors: M Latka, G Grey, K Fielding, L Bekker, K Mlisana, M Nchabeleng, G DeBruin, M Allen, J Kublin and G Churchyard

Citation: Retrovirology 2009 6(Suppl 3):P187

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P13-06. DARPin-based microbicide strategies to block HIV entry

Authors: A Mann, A Krarup and A Trkola

Citation: Retrovirology 2009 6(Suppl 3):P188

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P14-01. Care and treatment for volunteers in IAVI-sponsored HIV vaccine clinical trials in India

Authors: S Kochhar, J Excler and P Fast

Citation: Retrovirology 2009 6(Suppl 3):P189

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P14-02. Social impact events in Phambili, the first phase 2B HIV vaccine trial in South Africa

Authors: MA Allen, G Gray, G Churchyard, L Bekker, M Nchabeleng, K Mlisana, B Metch, Z Moodie, S Roux, M Mathebula, T Bennie and J Kublin

Citation: Retrovirology 2009 6(Suppl 3):P190

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P14-03. HIV-specific T-lymphocyte proliferative responses induced by a multigene multiclade HIV-1 DNA/MVA heterologous vaccine in Tanzanian volunteers

Authors: S Aboud, F Mhalu, M Bakari, J Lifson, E Lyamuya, M Marovich, J Cox, E Sandstrom, G Biberfeld and C Nilsson

Citation: Retrovirology 2009 6(Suppl 3):P191

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P14-04. HIV-SELECTEST EIA and rapid test: a novel assay for differential diagnosis of HIV infections in the face of vaccine-generated antibodies

Authors: S Khurana, PJ Norris, MP Busch, K Mlisana, AK Salim, E Hunter and H Golding

Citation: Retrovirology 2009 6(Suppl 3):P192

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P14-05. Recruitment, retention and participation impact events among women participating in phase III community trial in Thailand

Authors: P Pitisuttithum, S Rerks-Ngarm, J Kaewkungwal, S Nitayaphan, C Khamboonruang, P Kunasol, P Suntharasamai, MW Benenson and JH Kim

Citation: Retrovirology 2009 6(Suppl 3):P193

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P14-06. Phase 1 safety and immunogenicity randomised controlled trial of a vaginal gp140 vaccine

Authors: DJ Lewis, CJ Lacey, S Jeffs, T Cole, C Fraser, R Wiggins, M Woodrow, A Cope, C Cai, E Giemza, A Mahmhoud, D Katinger, M Cranage and R Shattock

Citation: Retrovirology 2009 6(Suppl 3):P194

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P14-07. Offering new prevention modalities in HIV vaccine trials: experience with male circumcision in the Phambili trial

Authors: G de Bruyn, K Mlisana, B Metch, G Churchyard, M Nchabeleng, L Bekker, S Roux, N Naicker, M Latka, L Corey, J Kublin and G Gray

Citation: Retrovirology 2009 6(Suppl 3):P195

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P14-08. Intramuscular DNA delivery by electroporation leads to greatly enhanced systemic and mucosal immune responses and control of SIVmac251 challenge

Authors: GN Pavlakis, M Rosati, V Patel, A Valentin, C Bergamaschi, V Kulkarni, R Jalah, A von Gegerfelt, C Ohlen, A Khan, R Draghia-Akli, K Van Rompay and BK Felber

Citation: Retrovirology 2009 6(Suppl 3):P196

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P14-09. Use of HIV rapid tests for assessment of persistence of vaccine induced antibodies among HIV vaccine recipients

Authors: E Karita, K Kayitenkore, R Bayingana, F Sebahungu, J Bizimana, K Grabowski, A Tichacek, C Schmidt, P Fast, E Hunter and S Allen

Citation: Retrovirology 2009 6(Suppl 3):P197

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF
P14-10. Comparable immunogenicity of VRC DNA and rAd5 HIV-1 vaccines delivered by intramuscular, subcutaneous and intradermal routes in healthy adults (VRC 011)

Authors: JE Ledgerwood, L Novik, ME Enama, IJ Gordon, LA Holman, MC Nason, RT Bailer, M Roederer, RA Koup, JR Mascola, GJ Nabel and BS Graham

Citation: Retrovirology 2009 6(Suppl 3):P198

Content type: Poster presentation Published on: 22 October 2009
- View Full Text
- View PDF

AIDS Vaccine 2009

Meeting abstracts

Follow

Annual Journal Metrics

Retrovirology

Contact us